Life Sciences

Some scientists turn down money from pharma industry

Pharma Compliance Alert, April 23, 2008

A group of academic scientists decided not to accept money from the pharmaceutical and medical device industries, according to a New York Times article.
 
The members of the group, which includes Peter Libby, chief of cardiovascular medicine at Harvard?s Brigham Brigham and Women?s Hospital, Kelly D. Brownell, director of the Rudd Center for Food Policy and Obesity at Yale University, and Eric P. Winer, director of the Breast Oncology Center at the Dana-Farber Cancer Institute at Harvard University, says they may still work with the industries to help draw up and interpret studies, but will no longer accept money to serve as speakers or sit on advisory boards, according to the article.
 
The scientists said accusations of ethical conflicts led them to decide to stop accepting money from the pharmaceutical and device industries.

Comments

0 comments on “Some scientists turn down money from pharma industry

 

Most Popular

Related Articles